In this article, we are going to take a look at where Capricor Therapeutics, Inc. (NASDAQ:CAPR) stands against other worst high-risk high-reward growth stocks to buy. On March 14, Tom Lee managing ...

SAN DIEGO, March 07, 2025 (GLOBE NEWSWIRE) -- Capricor Therapeutics (NASDAQ: CAPR), a biotechnology company developing transformative cell and exosome-based therapeutics for the treatment of rare ...

CAPR stock opened at $12.86 on Friday. Capricor Therapeutics has a one year low of $3.52 and a one year high of $23.40. The company’s fifty day moving average price is $14.06 and its 200-day ...

Capricor Therapeutics (CAPR) released expectation-beating results for the fourth quarter, sending the shares up over 5% in aftermarket trading. This comes on the heels of the company achieving a ...

CAPRICOR THERAPEUTICS ($CAPR) posted quarterly earnings results on Wednesday, March 19th. The company reported earnings of -$0.16 per share, beating estimates of -$0. ...

Five males and two female transmitochondrial chimeras have been generated after injection of CAPr ES cells into blastocysts. Two males and two females have been analyzed for levels of wild-type ...